DAMORA THERAPEUT Stock Price, News & Analysis
Why is DMRA Stock Down Today?
Company Description
DAMORA THERAPEUT (NASDAQ: DMRA) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $1.6B, ranking #2,398 among all listed U.S. companies by market cap.
DMRA stock has gained 1.2% over the past year. Shares last traded at $25.82.
On a trailing twelve-month basis, DAMORA THERAPEUT reported net income of -$209.8M and diluted earnings per share of $-23816.00.
This page provides a comprehensive overview of DMRA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
DAMORA THERAPEUT (DMRA) stock last traded at $25.82, down 0.90% from the previous close. Over the past 12 months, the stock has gained 1.2%. At a market capitalization of $1.6B, DMRA is classified as a small-cap stock with approximately 60.3M shares outstanding.
Latest News
DAMORA THERAPEUT has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include management, earnings. View all DMRA news →
SEC Filings
DAMORA THERAPEUT has filed 5 recent SEC filings, including 4 Form 4, 1 Form 3. The most recent filing was submitted on April 1, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DMRA SEC filings →
Financial Highlights
operating income reached -$210.9M, and net income was -$209.8M. Diluted earnings per share stood at $-23816.00. The company generated -$6.7M in operating cash flow. With a current ratio of 12.98, the balance sheet reflects a strong liquidity position.
Upcoming Events
IND/CTA submission expected
Proof-of-concept datasets begin
DAMORA THERAPEUT has 2 upcoming scheduled events. The next event, "IND/CTA submission expected", is scheduled for May 1, 2026 (in 18 days). Investors can track these dates to stay informed about potential catalysts that may affect the DMRA stock price.
Short Interest History
Short interest in DAMORA THERAPEUT (DMRA) currently stands at 827.2 thousand shares, up 93.4% from the previous reporting period, representing 1.4% of the float. Over the past 12 months, short interest has increased by 93.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for DAMORA THERAPEUT (DMRA) currently stands at 2.5 days, up 26.8% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 26.8% over the past year, indicating either rising short interest or declining trading volume.
DMRA Company Profile & Sector Positioning
DAMORA THERAPEUT (DMRA) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ. In monthly performance, the stock ranks #2,076 among all tracked companies.